Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential

Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone · 2024

Read Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential by Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678268.txt.

Description

Maria Gilardini Montani, Rossella Benedetti, and Mara Cirone review, in 2024, a gene-silencing enzyme as a cancer drug target. The enzyme, EZH2, tags DNA-packaging proteins to switch genes off and steers cell division, specialization, and death. In many cancers it is overactive, silencing tumor suppressors and helping tumors hide from the immune system.

The review walks through how the enzyme controls suppressor genes and growth drivers, how it shapes anti-cancer immunity, and how chemical modifications tune its own stability. Strategies to block it, from direct inhibitors to combination approaches, close the survey. The authors weigh its therapeutic promise across cancer types.

Catalog record

CREATORMaria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11678268

Browse the full library · About the Tower of Babel